MIGUEL ÁNGEL
LÓPEZ RUZ
PROFESOR TITULAR DE UNIVERSIDAD
![Foto de MIGUEL ÁNGEL](/img/nophoto.png)
![Foto de Hospital Universitario San Cecilio](/img/noimage_org.png)
Hospital Universitario San Cecilio
Granada, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario San Cecilio (20)
2024
-
Long or complicated mpox in patients with uncontrolled HIV infection
Journal of Medical Virology, Vol. 96, Núm. 3
-
The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers
Journal of Clinical Investigation, Vol. 134, Núm. 8
2022
-
DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks)
Viruses, Vol. 14, Núm. 3
-
Rildo: Real-World Multicenter Study on the Effectiveness and Safety of Single-Tablet Regimen of Dolutegravir plus Rilpivirine in Treatment-Experienced People Living with HIV
Viruses, Vol. 14, Núm. 12
2020
-
Genetic diversity of HIV in seminal plasma remains higher than in blood after short-term antiretroviral therapy
Sexually Transmitted Infections, Vol. 96, Núm. 5, pp. 337-341
2017
-
Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 3, pp. 487-494
2016
2015
-
Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 34, Núm. 11, pp. 2247-2255
2014
2009
-
Resistencias genotípicas en pacientes con VIH-1 y grados de viremia persistentemente bajos
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 27, Núm. 2, pp. 75-80
2008
-
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903
Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092
-
Efficacy of pegylated interferon plus ribavirin treatment in HIV/ hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone
Journal of Antimicrobial Chemotherapy, Vol. 62, Núm. 6, pp. 1365-1373
2005
-
A case-control study of HIV patients with the K65R mutation in the reverse transcriptase gene with virological failure [2]
AIDS
-
Simplicity and efficacy of a once-daily antiretroviral regimen with didanosine, lamivudine, and efavirenz in naïve patients: The VESD study
HIV Clinical Trials, Vol. 6, Núm. 6, pp. 320-328
1998
-
Comparative study of bacteremias caused by Enterococcus spp. with and without High-level resistance to gentamicin
Journal of Clinical Microbiology, Vol. 36, Núm. 2, pp. 520-525
1997
-
Imágenes nodulares hipodensas en bazo en un paciente con infección por el virus de la inmunodeficiencia humana
Revista Clinica Espanola, Vol. 197, Núm. 7, pp. 529-530
-
Meningitis por Streptococcus pneumoniae y Haemophilus influenzae en un adulto no inmunodeprimido [3]
Enfermedades Infecciosas y Microbiologia Clinica
1996
-
Frequency of Subclinical Visceral Leishmaniasis in HIV-1-Infected Patients in Spain
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 15, Núm. 3, pp. 263-264
1988
-
Bone marrow aplasia in patient suffering A.I.D.S. treated with trimethoprim-Sulphamethoxazole
Anales de Medicina Interna, Vol. 5, Núm. 3, pp. 141-145
-
Hepatitis caused by carbamacepine
Anales de Medicina Interna, Vol. 5, Núm. 12, pp. 644